Bryan Borzykowski is a Toronto-based business writer and editor focusing on investing, personal finance and small business. He writes investing features for CNBC and contributes to the New York Times, CNNMoney, BBC, Canadian Business magazine and the Globe and Mail. He's also written three personal finance and investing books. Follow him on Twitter: @bborzyko.
The first ETF to invest in marijuana stocks has launched in Canada, but there's plenty of reason for investors to be high on skepticism.
Latin American stocks are providing heady returns for investors. Here's why the region should continue to see even stronger gains ahead.
Obamacare repeal and failed insurance mergers have been dominating health-care headlines, but some surprise stock winners may emerge.
2017 is poised to be a make-or-break year for Europe, and so far investors are betting on its stocks. But there are big risks to the rally.
Trumponomics has already affected Canada's market performance. US and Canada trade relations could be next.
There are buying opportunities in biotech and drug stocks despite the backlash from the repeal of Obamacare.
Many blue-chips in various sectors — from biotech to energy — are still trading at low valuations and offer value for investors.
The president-elect plans to revitalize our nation's roads, bridges and airports. Here's how to find stock plays poised to benefit.
The top fund managers of 2016 are contrarian investors who are betting on small caps and commodities, not companies on the Dow.